Condition 1: Hot flushes. Condition 2: Night sweats. Generalized hyperhidrosis
Conditions
Interventions
Intervention 1: Intervention group: Group A: After a visit by a gynecologist, they are discharged with paroxetine 20 mg once a day. At the same visit, a questionnaire prepared for the level of vasomot
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: All women who have vasomotor symptoms of menopause Age 40 to 65 years Having informed consent to participate in the study Lack of sensitivity to the drug bupivacaine that is to be used in stellate ganglion block. No contraindications for stellate ganglion block
Exclusion criteria
Exclusion criteria: Recent myocardial infarction Patients with coagulation disorders, considering the risk-benefit ratio in these patients. Glaucoma Pre-existing lateral nerve palsy Severe emphysema cardiac conduction block
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reducing menopausal hot flashes. Timepoint: At the beginning of the study, 7 and 14 days after the start of drug treatment. Method of measurement: General Anxiety Disorder-7 (GAD-7) questionnaire.;Reducing menopausal night sweats. Timepoint: At the beginning of the study, 7 and 14 days after the start of drug treatment. Method of measurement: GAD-7 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShirin kooshki
Arak University of Medical Sciences
Outcome results
None listed